Skip to main content
. 2021 May 19;133(26):14778–14784. doi: 10.1002/ange.202103711

Table 1.

Steady‐state kinetic parameters for the H679A and H725A AspH variants. Apparent turnover numbers (kcatapp ), apparent Michaelis constants (Kmapp ), and specificity constants (kcat /Km ) of wt, H679A, and H725A His6‐AspH315‐758 determined for FeII, 2OG, and the hFX‐EGFD186‐124‐4Ser substrate peptide.[a,b]

Entry

AspH variant

kcatapp  [s−1]

Kmapp  [μM]

kcat /Km

[mM−1 s−1]

1

FeII[c]

wt

0.24±0.04

7.2±2.6

33.3±13.2

H679A

0.18±0.01

4.4±0.8

40.9±7.8

H725A

0.09±0.01

12.3±3.0

7.3±2.0

2

FeII[d]

wt

0.27±0.04

4.3±1.6

62.8±25.2

H679A

0.19±0.01

2.7±0.5

70.4±13.6

H725A

0.10±0.01

8.1±1.8

12.3±3.0

3

2OG

wt

0.31±0.03

1.1±0.4

282±106

H679A

0.18±0.01

109±20

1.7±0.3

H725A

0.08±0.01

211±65

0.38±0.13

4

hFX‐EGFD186‐124‐4Ser[e]

wt[f]

n.d.

n.d.

n.d.

H679A

0.18±0.01

1.5±0.3

120±24.9

H725A

0.10±0.02

1.7±1.1

58.8±39.8

[a] Determined using 0.2 μM AspH variant or 0.1 μM wt AspH by SPE‐MS. Detailed analyses are given in Supporting Figures S4–S6. [b] Mean of three independent runs (n=3; mean ± standard deviation, SD). [c] Without L‐ascorbate (LAA). [d] With LAA. [e] Km and kcat values were determined monitoring the hydroxylation of the hFX‐EGFD186‐124‐4Ser substrate peptide (Supporting Figure S2a). [f] Apparent substrate inhibition combined with low detectability of the peptide at low concentrations prevented determination.